Digital Pathology Market Size, Share, Trends, Growth 2032

Digital Pathology Market Size And Industry Analysis

The global digital pathology market size was worth around USD 725.10 million in 2021 and is estimated to grow to about USD 1,493.66 million by 2028, with a compound annual growth rate (CAGR) of approximately 12.8 percent over the forecast period. The report analyzes the Digital Pathology market’s drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the Digital Pathology market.

Request Free Sample

Digital Pathology Market: Overview

Digital Pathology enables laboratories to provide results of tests and diagnoses via digital means and is gaining popularity as advancements in healthcare technology are taking over the healthcare infrastructure across the world.  The COVID-19 pandemic resulted in a hike of demand for Digital Pathology as they were compatible with the social distancing and lockdown norms.

Increasing technological proliferation, rapid advancements in Digital Pathology, increasing demand for quality treatment and diagnostics, increasing prevalence of deadly diseases, and rising demand for efficient laboratory testing are some major factors that propel the Digital Pathology market potential over the forecast period.

However, high costs and lack of skilled professionals will hamper the Digital Pathology market growth through 2028 and are expected to slow down the overall market.

Request Free Sample

COVID-19 Impact:

The COVID-19 pandemic led to lockdown restrictions and social distancing which limited outdoor activity to a major extent and had an adverse impact on most of life aspects and businesses as well. However, this was not the case with the Digital Pathology market which saw an increase in demand in 2020 as coronavirus infections plagued the world.

Digital pathology saw a rise in popularity amidst the COVID-19 lockdown restrictions as testing was important but conventional methods proved to be harmful and risked infections among healthcare professionals and hence propelled the demand for Digital Pathology solutions on a global scale.

As the world returns to normal the Digital Pathology market is also expected to gain potential over the post-pandemic era and we are expected to see growth at a stellar CAGR through 2028.

Digital Pathology Market: Growth Drivers

Increasing Demand for Lab Efficiency

Technological proliferation has increased in all aspects of life and even in labs, digital pathology is helping cut costs and increasing efficiency and productivity. Faster pathology results can facilitate better diagnostic and better treatment opportunities and these factors are subsequently driving the demand for the Digital Pathology market growth through the forecast period. The COVID-19 pandemic further bolstered the demand for Digital Pathology as it was deployed to contain the infection spread among healthcare professionals under lockdown restrictions.

Digital Pathology Market: Restraints

High Costs to Hinder market

Digital Pathology solutions are costly and this is a major factor that restrains the adoption of these systems in healthcare infrastructure across the globe. This factor will major drag down growth in emerging economies like India and China where spending potential is less and hence will slow down the overall growth of the Digital Pathology market over the forecast period.  Apart from this lack of trained individuals to operate these advanced systems will also have a restraining effect on the Digital Pathology market through 2028.

Global Digital Pathology Market: Segmentation

The global Digital Pathology market is segregated based on type, product type, application, end user, and region.

By Product, the market is divided into Scanners, Software, Communication Systems, and Storage Systems. The scanners segment is anticipated to emerge as the most lucrative one over the forecast period. These devices are expensive and essential in digital pathology hence their value share is high in the global Digital Pathology marketplace and this stance will be maintained over the forecast period as well.

By Application, the Digital Pathology market is segmented into Drug Discovery, Disease Diagnosis, Teleconsultation, and Training & Education. The drug discovery segment is anticipated to give a dominant outlook over the forecast period. Rising demand for drugs and increasing research and development activity across the world for new pharmaceuticals are expected to be prominent factors driving demand for this segment through 2028.  

Global Digital Pathology Market: Report Scope:

To know more about this report, request a sample copy.

Recent Developments

• In September 2021 – Visiopharm a firm based in Denmark and Agilent Technologies, Inc. based in the United States announced a collaboration to develop a AI-driven precision pathology software to advance the Digital Pathology market. This was aimed at advancing the pathlogy portfolio of both the companies.

Regional Landscape

Owing to the presence of a developed healthcare infrastructure the Digital Pathology market in North America is expected to hold a dominant outlook over the forecast period. Increasing spending on research and development activities in this region is expected to be a prominent driver through 2028. Rising support from the government, increasing adoption of technology in healthcare, favorable reimbursement policies, and increasing demand for better diagnostics and treatment are other factors that will drive the Digital Pathology market growth over the forecast period. The Unites States is anticipated to be the most lucrative country in this region through 2028.

Competitive Landscape

Some of the main competitors dominating the global Digital Pathology market include -  Leica Biosystems (US), Koninklijke Philips N.V. (Netherlands), and Hamamatsu Photonics K.K. (Japan), Roche (Switzerland), 3DHISTECH (Hungary), Apollo Enterprise Imaging (US), XIFIN (US), Huron Digital Pathology (Canada), Visiopharm A/S (Denmark), Corista (US), Indica Labs (US), Objective Pathology Services (Canada), Sectra AB (Sweden), OptraSCAN (India), Glencoe Software (US), KONFOONG BIOTECH INTERNATIONAL CO., LTD (China), Inspirata Inc. (US), Mikroscan Technologies (US), Proscia Inc. (US), and Kanteron Systems (Spain).

Global Digital Pathology market is segmented as follows:

By Product

• Scanners
• Software
• Communication Systems
• Storage Systems

By Type

• Human Pathology
• Veterinary Pathology

By Application

• Drug Discovery
• Disease Diagnosis
• Teleconsultation
• Training & Education

By End User

• Pharmaceutical & Biotechnology Companies
• Hospitals and Reference Laboratories
• Academic & Research Institutes

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France 
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa